CLINICAL / SCIENTIFIC PRESENTATION AND PUBLICATION HIGHLIGHTS
The information contained in each post on this page was factually accurate on the date it was issued and posted.
Jefferies London Healthcare Conference – Presentation
Webcast: Nov 18, 2021 at 3:00am EST Download: Click Here
Stifel 2021 Virtual Healthcare Conference – Presentation
Webcast: Nov 15, 2021 at 1:20pm EST Download: Click Here
Credit Suisse 30th Annual Healthcare Conference – Presentation
Webcast, Nov 10, 2021 at 4:20pm EST Download Presentation, Click Here
Sutro Biopharma to Participate in Three Upcoming Investor Conferences
SOUTH SAN FRANCISCO, Calif., Nov. 2, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...
2021 Wells Fargo Virtual Healthcare Conference – Presentation
Webcast, Sept 9, 2021 at 3:20pm EST
Sutro Biopharma to Participate in the 2021 Wells Fargo Virtual Healthcare Conference
SOUTH SAN FRANCISCO, Calif., Sept. 1, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...
12th Annual Wedbush PacGrow Healthcare Virtual Conference 2021 – Presentation
Webcast, Aug 11, 2021 at 11:20am PST Download Presentation, Click Here
Sutro Biopharma to Participate in the 12th Annual Wedbush PacGrow Healthcare Virtual Conference
SOUTH SAN FRANCISCO, Calif., July 29, 2021 – Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application of precise protein engineering and rational design to create next-generation cancer and...
American Society of Clinical Oncology (ASCO) Virtual Annual Meeting 2021 – Poster
Phase 1 Dose-Escalation Study of STRO-002, an Anti-Folate-Receptor Alpha Antibody Drug Conjugate, in Patients with Advanced, Progressive, Platinum-Resistant/-Refractory Epithelial Ovarian Cancer Download Poster, CLICK HERE
American Society of Clinical Oncology (ASCO) Virtual Annual Meeting 2021 – Presentation
Phase 1 Dose-Escalation Study of STRO-002, an Anti-Folate-Receptor Alpha Antibody Drug Conjugate, in Patients with Advanced, Progressive, Platinum-Resistant/-Refractory Epithelial Ovarian CancerDownload Presentation, CLICK HERE